September 24, 2026 · Gut · DOI: 10.1136/gutjnl-2026-339505

Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies

Listen to this summary

The authors convened a multidisciplinary panel to establish expert consensus on the design of clinical trials evaluating systemic therapy in patients with hepatocellular carcinoma (HCC) undergoing surgical and locoregional therapies. They aimed to address challenges in trial design due to the heterogeneity of HCC by defining inclusion criteria, risk stratification, treatment strategies, and appropriate endpoints. The consensus emphasizes the importance of selecting high-risk patient populations and using clinically relevant outcomes to rigorously assess the efficacy and safety of these therapies.

Mark Yarchoan, Josep M Llovet, Robin Kate Kelley, Richard Finn, Neehar D Parikh, Parissa Tabrizian, Adam M Burgoyne, Vatche G Agopian, Nina N Sanford, Hop S Tran Cao, Siddharth A Padia, Arndt Vogel, Robert J Lewandowski, Garcia-Reyes Kirema, Ruitao Lin, Neil Mehta, Gonzalo Sapisochin, Adam Yopp, Augusto Villanueva, Karim Halazun, David J Pinato, Edward Kim, Julie K Heimbach, Anjana Pillai, Riad Salem, Anthony El-Khoueiry, Amit G Singal

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play